how does the market with the lowest sos because they have never performed have some of the smallest growth numbers. It's almost like you get rewarded for not doing your job.
Someone needs to ask this question! SDHMs need to speak up! LA talks about how good they are doing with FQHCs, so stupid and tired. With their quota you get 1 FQHC and you win. So dumb and unfair to the rest of us.
Layers upon layers. Too many silos. CE, NPS, and now this hybrid of MPA role. All have their own managers, RDs, and EDs. Novartis needs to cutback the leadership levels. Too many chiefs, not enough Indians. With 2025 expected performance being way below expectations, this is where the cuts need to happen.